The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials. [electronic resource]
- Pacing and clinical electrophysiology : PACE Oct 2004
- 1405-10 p. digital
Publication Type: Journal Article; Meta-Analysis
0147-8389
10.1111/j.1540-8159.2004.00645.x doi
Angiotensin II Type 1 Receptor Blockers--therapeutic use Angiotensin-Converting Enzyme Inhibitors--therapeutic use Atrial Fibrillation--etiology Cardiovascular Diseases--complications Humans Randomized Controlled Trials as Topic